Amoéba S.A. (ALMIB.PA)
Chassieu, FR
Amoéba S.A. focuses on the development and commercialization of anti-microbial and anti-fungal products. The company's primary innovation centers on harnessing the unique properties of the Willaertia magna C2c Maky amoeba, which it is applying across various fields. These applications are designed to mitigate biological risks in critical areas like water purification, the treatment of human injuries, and safeguarding agricultural crops. Established in 2010, Amoéba S.A. is based in Chassieu, France.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.69% | +2.74% | +3.45% | -12.62% | -6.74% | -15.09% | -21.74% | +58.17% | -54.36% | -97.09% | -89.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%-100.0% Q4'25: -100.0% (vs Q4'23)
-
EPS growth Agricultural Inputs: +23.0%+7.7% Q4'25: +78.6% (vs Q4'23)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%—
-
EBIT margin Agricultural Inputs: +9.7%—
-
ROIC Agricultural Inputs: +7.4%-346.6%
-
Share dilution Agricultural Inputs: +0.0%+38.9% Q4'25: +98.8% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×-1.64× Q4'25: -0.75× (vs Q4'23)
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
140.94
est: 500.0K (-100.0%)
|
125.95
est: 500.0K (-100.0%)
|
161.25
est: 100.0K (-99.8%)
|
122.28
est: 720.0K (-100.0%)
|
122.5K
est: 3.00M (-95.9%)
|
—
est: 200.0K (-100.0%)
|
—
est: 2.10M (-100.0%)
|
601.6K
est: 682.5K (-11.8%)
|
—
est: 300.0K (-100.0%)
|
4.05M
3.04M – 6.08M
+1,250.0% YoY
|
14.05M
12.20M – 15.90M
+246.9% YoY
|
43.00M
36.18M – 52.24M
+206.0% YoY
|
103.30M
86.93M – 125.50M
+140.2% YoY
|
| EBITDA |
-3.83M
est: 100.0K (-3,925.4%)
|
-5.45M
est: 100.0K (-5,549.9%)
|
-5.31M
est: 20.0K (-26,660.3%)
|
-5.48M
est: 144.0K (-3,907.9%)
|
-3.72M
est: 600.0K (-720.0%)
|
-5.05M
est: 40.0K (-12,732.4%)
|
-5.01M
est: 420.0K (-1,292.8%)
|
-5.38M
est: 136.5K (-4,039.1%)
|
-7.47M
est: 60.0K (-12,550.2%)
|
810.0K
607.5K – 1.22M
+1,250.0% YoY
|
2.81M
2.44M – 3.18M
+246.9% YoY
|
8.60M
7.24M – 10.45M
+206.0% YoY
|
20.66M
17.39M – 25.10M
+140.2% YoY
|
| EBIT |
-3.97M
est: 100.0K (-4,068.3%)
|
-5.69M
est: 100.0K (-5,789.2%)
|
-6.04M
est: 20.0K (-30,289.2%)
|
-6.07M
est: 144.0K (-4,313.2%)
|
-5.45M
est: 600.0K (-1,009.2%)
|
-6.52M
est: 40.0K (-16,397.4%)
|
-5.87M
est: 420.0K (-1,497.3%)
|
-6.18M
est: 136.5K (-4,629.3%)
|
-7.47M
est: 60.0K (-12,550.2%)
|
810.0K
607.5K – 1.22M
+1,250.0% YoY
|
2.81M
2.44M – 3.18M
+246.9% YoY
|
8.60M
7.24M – 10.45M
+206.0% YoY
|
20.66M
17.39M – 25.10M
+140.2% YoY
|
| Net Income |
-4.0K
est: -39.21M (+100.0%)
|
-5.8K
est: -39.21M (+100.0%)
|
-6.2K
est: -41.19M (+100.0%)
|
-7.2K
est: -53.83M (+100.0%)
|
-7.25M
est: -45.68M (+84.1%)
|
-8.16M
est: -45.81M (+82.2%)
|
-7.82M
est: -21.84M (+64.2%)
|
-6.59M
est: -7.36M (+10.5%)
|
-8.30M
est: -7.31M (-13.6%)
|
-9.44M
-10.07M – -8.81M
-29.1% YoY
|
-3.57M
-4.41M – -2.74M
+62.2% YoY
|
6.80M
5.47M – 8.82M
+290.4% YoY
|
41.34M
32.82M – 52.89M
+508.0% YoY
|
| SGA |
2.8K
est: 1.47M (-99.8%)
|
3.03M
est: 1.47M (+106.7%)
|
3.10M
est: 293.0K (+957.7%)
|
3.02M
est: 2.11M (+43.3%)
|
2.57M
est: 8.79M (-70.8%)
|
4.00M
est: 586.1K (+583.2%)
|
3.18M
est: 6.15M (-48.3%)
|
4.05M
est: 2.00M (+102.5%)
|
5.90M
est: 879.1K (+570.6%)
|
11.87M
8.90M – 17.80M
+1,250.0% YoY
|
41.17M
35.74M – 46.60M
+246.9% YoY
|
126.00M
106.03M – 153.09M
+206.0% YoY
|
302.70M
254.72M – 367.76M
+140.2% YoY
|
| EPS |
-0.90
est: -0.79 (-13.9%)
|
-1.00
est: -0.79 (-26.6%)
|
-1.04
est: -0.83 (-25.3%)
|
-1.20
est: -1.08 (-10.6%)
|
-0.92
est: -0.92 (+0.0%)
|
-0.50
est: -0.92 (+45.8%)
|
-0.44
est: -0.44 (+0.0%)
|
-0.13
est: -0.10 (-30.0%)
|
-0.12
est: -0.11 (-14.3%)
|
-0.14
-0.15 – -0.13
-33.3% YoY
|
-0.05
-0.06 – -0.04
+64.3% YoY
|
0.10
0.08 – 0.13
+300.0% YoY
|
0.60
0.48 – 0.77
+500.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares International Small-Cap Equity Factor ETF ISCF | 0.01% | 79.9K | 0.24% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jean-Francois Doucet | General Director | 184.5K | male |
| Jean-Marc Petat | MD of Green 4 Agro & Director | — | male |
| Sandrine Troussieux | Scientific Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALMIB.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
